United States Chronic Kidney Disease (CKD) Drugs Market Report 2016

December 2016 | 114 pages | ID: UFD2F38624CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Chronic Kidney Disease (CKD) Drugs

Revenue, means the sales value of Chronic Kidney Disease (CKD) Drugs

This report studies sales (consumption) of Chronic Kidney Disease (CKD) Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Johnson & Johnson
• Abbott Laboratories
• Sanofi
• F. Hoffmann-La Roche
• Takeda Pharmaceuticals
• Actavis
• Akebia Therapeutic
• Raptor Pharmaceuticals
• Rockwell Medical
• AMAG Pharmaceuticals
• Reata Pharmaceuticals
• Cara Therapeutics
• FibroGen

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Chronic Kidney Disease (CKD) Drugs in each application, can be divided into

• Hospital use
• Clinic use
• Household

Contents

United States Chronic Kidney Disease (CKD) Drugs Market Report 2016

1 CHRONIC KIDNEY DISEASE (CKD) DRUGS OVERVIEW

1.1 Product Overview and Scope of Chronic Kidney Disease (CKD) Drugs
1.2 Classification of Chronic Kidney Disease (CKD) Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Chronic Kidney Disease (CKD) Drugs
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Household
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Chronic Kidney Disease (CKD) Drugs (2011-2021)
  1.4.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Chronic Kidney Disease (CKD) Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Chronic Kidney Disease (CKD) Drugs Average Price by Manufactures (2015 and 2016)
2.4 Chronic Kidney Disease (CKD) Drugs Market Competitive Situation and Trends
  2.4.1 Chronic Kidney Disease (CKD) Drugs Market Concentration Rate
  2.4.2 Chronic Kidney Disease (CKD) Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Chronic Kidney Disease (CKD) Drugs Price by Type (2011-2016)
3.4 United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Johnson & Johnson
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories
  5.2.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 F. Hoffmann-La Roche
  5.4.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Takeda Pharmaceuticals
  5.5.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Actavis
  5.6.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Actavis Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Akebia Therapeutic
  5.7.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Raptor Pharmaceuticals
  5.8.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Rockwell Medical
  5.9.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Rockwell Medical Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 AMAG Pharmaceuticals
  5.10.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Reata Pharmaceuticals
5.12 Cara Therapeutics
5.13 FibroGen

6 CHRONIC KIDNEY DISEASE (CKD) DRUGS MANUFACTURING COST ANALYSIS

6.1 Chronic Kidney Disease (CKD) Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Chronic Kidney Disease (CKD) Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS MARKET FORECAST (2016-2021)

10.1 United States Chronic Kidney Disease (CKD) Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2016-2021)
10.3 United States Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2016-2021)
10.4 Chronic Kidney Disease (CKD) Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chronic Kidney Disease (CKD) Drugs
Table Classification of Chronic Kidney Disease (CKD) Drugs
Figure United States Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2015
Table Application of Chronic Kidney Disease (CKD) Drugs
Figure United States Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Household Examples
Figure United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2021)
Figure United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Table United States Chronic Kidney Disease (CKD) Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers
Figure 2016 Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers
Table United States Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers
Table 2016 United States Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers
Table United States Market Chronic Kidney Disease (CKD) Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Chronic Kidney Disease (CKD) Drugs Average Price of Key Manufacturers in 2015
Figure Chronic Kidney Disease (CKD) Drugs Market Share of Top 3 Manufacturers
Figure Chronic Kidney Disease (CKD) Drugs Market Share of Top 5 Manufacturers
Table United States Chronic Kidney Disease (CKD) Drugs Sales by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2015
Table United States Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Chronic Kidney Disease (CKD) Drugs by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Price by Type (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales by Application (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2015
Table United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Akebia Therapeutic Basic Information List
Table Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Rockwell Medical Basic Information List
Table Rockwell Medical Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rockwell Medical Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table AMAG Pharmaceuticals Basic Information List
Table AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Cara Therapeutics Basic Information List
Table Cara Therapeutics Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cara Therapeutics Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table FibroGen Basic Information List
Table FibroGen Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table FibroGen Chronic Kidney Disease (CKD) Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chronic Kidney Disease (CKD) Drugs
Figure Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs
Figure Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chronic Kidney Disease (CKD) Drugs Major Manufacturers in 2015
Table Major Buyers of Chronic Kidney Disease (CKD) Drugs
Table Distributors/Traders List
Figure United States Chronic Kidney Disease (CKD) Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Chronic Kidney Disease (CKD) Drugs Production Forecast by Type (2016-2021)
Table United States Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Application (2016-2021)